SEGMENT INFORMATION (Tables)

12 Months Ended

Dec. 31, 2024

Segment Reporting [Abstract]

Schedule of Segment Reporting Information

Segment results for the year ended December 31, 2024 are shown below ($ in millions):

	Total		Intelligent Operating Solutions		Precision Technologies		Advanced Healthcare Solutions		Unallocated Corporate Costs and Other
Sales	$	6,231.8	$	2,714.7	$	2,229.4	$	1,287.7	$	—
Cost of sales	(2,500.8)		(888.6)		(1,073.3)		(538.9)		—
Gross profit	3,731.0		1,826.1		1,156.1		748.8		—
Operating expenses	(2,587.5)		(1,121.5)		(719.2)		(593.2)		(153.6)
Gain on sale of property (a)	63.1		—		63.1		—		—
Operating profit (loss)	1,206.6		704.6		500.0		155.6		(153.6)
Non-operating income (expense), net
Interest expense, net	(152.8)		—		—		—		(152.8)
Loss from divestiture (a)	(25.6)		—		—		—		(25.6)
Other non-operating expense, net	(58.6)		—		—		—		(58.6)
Earnings before income taxes	$	969.6	$	704.6	$	500.0	$	155.6	$	(390.6)
Depreciation and amortization expenses	$	(543.9)	$	(228.8)	$	(113.0)	$	(201.2)	$	(0.9)
Capital expenditure	$	(120.4)	$	(67.6)	$	(34.3)	$	(15.6)	$	(2.9)
(a) Refer to Note 4 and Note 3, respectively, for further detail on Gain on sale of property, and Loss from divestiture.

Segment results for the year ended December 31, 2023 are shown below ($ in millions):

	Total		Intelligent Operating Solutions		Precision Technologies		Advanced Healthcare Solutions		Unallocated Corporate Costs and Other
Sales	$	6,065.3	$	2,612.2	$	2,223.7	$	1,229.4	$	—
Cost of sales	(2,471.2)		(875.1)		(1,064.7)		(531.4)		—
Gross profit	3,594.1		1,737.1		1,159.0		698.0		—
Operating expenses	(2,460.4)		(1,108.3)		(614.8)		(596.4)		(140.9)
Operating profit (loss)	1,133.7		628.8		544.2		101.6		(140.9)
Non-operating income (expense), net
Interest expense, net	(123.5)		—		—		—		(123.5)
Other non-operating expense, net	(19.4)		—		—		—		(19.4)
Earnings before income taxes	$	990.8	$	628.8	$	544.2	$	101.6	$	(283.8)
Depreciation and amortization expenses	$	(456.8)	$	(219.4)	$	(30.8)	$	(202.6)	$	(4.0)
Capital expenditure	$	(107.8)	$	(55.7)	$	(29.1)	$	(17.7)	$	(5.3)

Segment results for the year ended December 31, 2022 are shown below ($ in millions):

	Total		Intelligent Operating Solutions		Precision Technologies		Advanced Healthcare Solutions		Unallocated Corporate Costs and Other
Sales	$	5,825.7	$	2,466.1	$	2,152.3	$	1,207.3	$	—
Cost of sales	(2,462.3)		(863.5)		(1,066.9)		(531.9)		—
Gross profit	3,363.4		1,602.6		1,085.4		675.4		—
Operating expenses	(2,358.1)		(1,083.2)		(581.8)		(579.8)		(113.3)
Russia exit and wind down costs (a)	(17.9)		—		—		—		(17.9)
Operating profit (loss)	987.4		519.4		503.6		95.6		(131.2)
Non-operating income (expense), net
Interest expense, net	(98.3)		—		—		—		(98.3)
Other non-operating expense, net	(15.6)		—		—		—		(15.6)
Earnings before income taxes	$	873.5	$	519.4	$	503.6	$	95.6	$	(245.1)
Depreciation and amortization expenses	$	(465.6)	$	(218.3)	$	(38.3)	$	(205.2)	$	(3.8)
Capital expenditure	$	(95.8)	$	(36.7)	$	(30.8)	$	(15.8)	$	(12.5)
(a) Refer to Note 1 for further detail on Russia exit and wind down costs.

Segment Assets:

	As of December 31,
($ in millions)	2024		2023
Intelligent Operating Solutions	$	6,320.1	$	6,550.0
Precision Technologies	4,691.9		3,064.3
Advanced Healthcare Solutions	5,008.6		5,211.7
Total segment assets	16,020.6		14,826.0
Other (a)	995.5		2,085.8
Total assets	$	17,016.1	$	16,911.8
(a) Other represents corporate assets which consist primarily of cash, property, plant, and equipment, and net deferred income tax assets.

Schedule of Operations in Geographical Areas

Operations in Geographic Areas:

	As of December 31,
($ in millions)	2024		2023
Property, plant and equipment, net:
United States	$	338.8	$	369.0
All other	94.3		70.8
Total	$	433.1	$	439.8